STOCK TITAN

Ambiq Micro CEO Fumihide Esaka sells 109,821 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Ambiq Micro, Inc. (AMBQ) Chief Executive Officer Fumihide Esaka exercised options for 109,821 common shares on November 12, 13 and 16, 2026, at exercise prices of $12.60 and $8.12 per share, and reported sales of 109,821 shares on those dates. Reported sale prices ranged from $43.9163 to $51.45 per share; footnotes identify several prices as weighted averages for multiple transactions. The transactions were under a Rule 10b5-1 plan; the footnote tied to the November 16 transactions gives May 15, 2026 as the plan’s adoption date.

Insider Esaka Fumihide
Role Chief Executive Officer
Sold 109,821 shs ($5.28M)
Approx. gross sale proceeds $5.28M
Approx. exercise cost $1.36M
Approx. pre-tax spread $3.92M
Share of Position Sold 19.8%
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F8, F12 5,000 $0.00 $0.00
Exercise Common Stock F8 5,000 $8.12 $41K
Sale Common Stock F8, F9 3,300 $43.9163 $145K
Sale Common Stock F8, F10 1,700 $44.4322 $76K
Exercise Stock Option (Right to Buy) F11 54,821 $0.00 $0.00
Exercise Common Stock 54,821 $12.60 $691K
Sale Common Stock F4 5,600 $45.4478 $255K
Sale Common Stock F5 9,325 $46.1061 $430K
Sale Common Stock F6 38,496 $47.2925 $1.82M
Sale Common Stock F7 1,400 $48.4423 $68K
Exercise Stock Option (Right to Buy) F11 50,000 $0.00 $0.00
Exercise Common Stock 50,000 $12.60 $630K
Sale Common Stock F1 17,400 $48.7624 $848K
Sale Common Stock F2 16,200 $49.9301 $809K
Sale Common Stock F3 16,000 $50.7148 $811K
Sale Common Stock 400 $51.45 $21K
Holdings After Transaction: Stock Option (Right to Buy) — 87,965 options (Direct); Common Stock — 443,900 shares (Direct)
Holdings Before and After: Stock Option (Right to Buy), 197,786 to 87,965 options (Direct); Common Stock, 443,900 to 443,900 shares (Direct)
Footnotes (12)
  1. F1. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.40 to $49.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $49.41 to $50.40 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.42 to $51.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.65 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.69 to $46.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.69 to $47.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. F7. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.71 to $48.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F8. The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026.
  9. F9. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.20 to $44.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. F10. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.21 to $45.03 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. F11. 1/4 of the shares subject to the option vested on January 1, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
  12. F12. 1/4 of the shares subject to the option vested on February 21, 2020, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Shares sold 109,821 shares Reported across November 12, 13 and 16, 2026
Options exercised 109,821 shares Reported across November 12, 13 and 16, 2026
Exercise prices $12.60 and $8.12 per share $12.60 for the November 12 and 13 exercises; $8.12 for the November 16 exercise
Reported sale prices $43.9163 to $51.45 per share Sales reported November 12, 13 and 16, 2026; several prices are weighted averages
Plan adoption date May 15, 2026 Adoption date stated in the footnote tied to the November 16 transactions
Rule 10b5-1 plan financial
"transactions occurred under a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sale price financial
"The reported price in Column 4 is a weighted average sale price"
vested in equal monthly installments technical
"shares subject to the option vested in equal monthly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AMBQ shares did Fumihide Esaka sell, and at what prices?

Fumihide Esaka reported selling 109,821 shares across November 12, 13 and 16, 2026, at reported prices from $43.9163 to $51.45 per share. Footnotes identify several listed prices as weighted averages for multiple transactions. The transactions were under a Rule 10b5-1 plan; the footnote tied to the November 16 transactions gives May 15, 2026 as the adoption date.

What options did Ambiq Micro CEO Fumihide Esaka exercise?

He exercised options for 50,000 shares on November 12 and 54,821 shares on November 13, 2026, each at $12.60 per share, and options for 5,000 shares on November 16 at $8.12 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Esaka Fumihide

(Last)(First)(Middle)
C/O AMBIQ MICRO, INC.
6500 RIVER PLACE BLVD BUILDING 7 STE 200

(Street)
AUSTIN TEXAS 78730

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ambiq Micro, Inc. [ AMBQ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/12/2026M50,000A$12.6493,900D
Common Stock11/12/2026S17,400D$48.7624(1)476,500D
Common Stock11/12/2026S16,200D$49.9301(2)460,300D
Common Stock11/12/2026S16,000D$50.7148(3)444,300D
Common Stock11/12/2026S400D$51.45443,900D
Common Stock11/13/2026M54,821A$12.6498,721D
Common Stock11/13/2026S5,600D$45.4478(4)493,121D
Common Stock11/13/2026S9,325D$46.1061(5)483,796D
Common Stock11/13/2026S38,496D$47.2925(6)445,300D
Common Stock11/13/2026S1,400D$48.4423(7)443,900D
Common Stock11/16/2026M(8)5,000A$8.12448,900D
Common Stock11/16/2026S(8)3,300D$43.9163(9)445,600D
Common Stock11/16/2026S(8)1,700D$44.4322(10)443,900D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$12.611/12/2026M50,000 (11)07/20/2034Common Stock50,000$094,279D
Stock Option (Right to Buy)$12.611/13/2026M54,821 (11)07/20/2034Common Stock54,821$039,458D
Stock Option (Right to Buy)$8.1211/16/2026M(8)5,000 (12)02/20/2029Common Stock5,000$048,507D
Explanation of Responses:
1. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.40 to $49.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $49.41 to $50.40 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.42 to $51.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.65 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.69 to $46.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.69 to $47.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.71 to $48.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026.
9. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.20 to $44.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.21 to $45.03 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. 1/4 of the shares subject to the option vested on January 1, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
12. 1/4 of the shares subject to the option vested on February 21, 2020, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.
/s/ Jeffrey Winzeler, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading